NAT2 and meningeal tuberculosis: This study examines the influence of varying isoniazid (INH) dosages and NAT2 gene polymorphisms on the clinical characteristics, therapeutic approaches, and prognostic outcomes of patients with tuberculous meningitis (TBM) within the specified region.